June 21, 2022
Taiho Pharmaceutical ended a shipment control on its anticancer agent Abraxane IV Infusion 100 mg (paclitaxel) on June 20, after securing sufficient inventories for the Japan market. In a letter issued the same day to patients and medical professionals, the...read more